Come up with a name for your new list and we'll add to it:
Oxxon Therapeutics was acquired by
Oxford BioMedica on March 12, 2007.
Oxxon Therapeutics is a mid-stage biotechnology company developing a portfolio of immunotherapeutics for infectious disease and cancer in man using its proprietary Heterologous PrimeBoost approach. Th…